These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33445785)

  • 1. The Long-Term Evolutionary History of Gradual Reduction of CpG Dinucleotides in the SARS-CoV-2 Lineage.
    Subramanian S
    Biology (Basel); 2021 Jan; 10(1):. PubMed ID: 33445785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Slowing Rate of CpG Depletion in SARS-CoV-2 Genomes Is Consistent with Adaptations to the Human Host.
    Kumar A; Goyal N; Saranathan N; Dhamija S; Saraswat S; Menon MB; Vivekanandan P
    Mol Biol Evol; 2022 Mar; 39(3):. PubMed ID: 35134218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Inference of Selection Underlying the Evolution of the Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2.
    Cagliani R; Forni D; Clerici M; Sironi M
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32238584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2.
    Di Gioacchino A; Šulc P; Komarova AV; Greenbaum BD; Monasson R; Cocco S
    Mol Biol Evol; 2021 May; 38(6):2428-2445. PubMed ID: 33555346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding genomic diversity, pan-genome, and evolution of SARS-CoV-2.
    Parlikar A; Kalia K; Sinha S; Patnaik S; Sharma N; Vemuri SG; Sharma G
    PeerJ; 2020; 8():e9576. PubMed ID: 32742815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2.
    Di Gioacchino A; Šulc P; Komarova AV; Greenbaum BD; Monasson R; Cocco S
    SSRN; 2020 May; ():3611280. PubMed ID: 32714120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
    Li X; Zai J; Zhao Q; Nie Q; Li Y; Foley BT; Chaillon A
    J Med Virol; 2020 Jun; 92(6):602-611. PubMed ID: 32104911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets.
    Chan AP; Choi Y; Schork NJ
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33239366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-genome variability in the dinucleotide composition of SARS-CoV-2.
    Digard P; Lee HM; Sharp C; Grey F; Gaunt E
    Virus Evol; 2020 Jul; 6(2):veaa057. PubMed ID: 33029383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heterogeneous landscape and early evolution of pathogen-associated CpG dinucleotides in SARS-CoV-2.
    Di Gioacchino A; Šulc P; Komarova AV; Greenbaum BD; Monasson R; Cocco S
    bioRxiv; 2020 Dec; ():. PubMed ID: 32511407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.
    Fung SY; Yuen KS; Ye ZW; Chan CP; Jin DY
    Emerg Microbes Infect; 2020; 9(1):558-570. PubMed ID: 32172672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses.
    Cagliani R; Forni D; Clerici M; Sironi M
    Infect Genet Evol; 2020 Sep; 83():104353. PubMed ID: 32387562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.
    Dinka H; Milkesa A
    Infect Genet Evol; 2020 Oct; 84():104386. PubMed ID: 32473977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes.
    Dilucca M; Forcelloni S; Georgakilas AG; Giansanti A; Pavlopoulou A
    Viruses; 2020 Apr; 12(5):. PubMed ID: 32366025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
    Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.
    Pachetti M; Marini B; Benedetti F; Giudici F; Mauro E; Storici P; Masciovecchio C; Angeletti S; Ciccozzi M; Gallo RC; Zella D; Ippodrino R
    J Transl Med; 2020 Apr; 18(1):179. PubMed ID: 32321524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Base Composition and Host Adaptation of the SARS-CoV-2: Insight From the Codon Usage Perspective.
    Roy A; Guo F; Singh B; Gupta S; Paul K; Chen X; Sharma NR; Jaishee N; Irwin DM; Shen Y
    Front Microbiol; 2021; 12():548275. PubMed ID: 33889134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses.
    Tan Y; Schneider T; Leong M; Aravind L; Zhang D
    mBio; 2020 May; 11(3):. PubMed ID: 32471829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short sequence motif dynamics in the SARS-CoV-2 genome suggest a role for cytosine deamination in CpG reduction.
    Sadykov M; Mourier T; Guan Q; Pain A
    bioRxiv; 2021 Jan; ():. PubMed ID: 34013262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.